CHANTEUX, Stéphanie,GOURDIN, Nicolas,PATUREL, Carine,PERROT, Ivan,ROSSI, Benjamin
申请号：
SG11202002192Q
公开号：
SG11202002192QA
申请日:
2018.10.05
申请国别(地区):
SG
年份:
2020
代理人:
摘要：
The present invention relates to methods of using compounds that inhibit the enzymatic activity of soluble human CD39 to treat cancer, including but not limited to the treatment of cancers characterized by CD73 expressing cells.
